NCT06511154

Brief Summary

Multiple sclerosis (MS) is a chronic, progressive, demyelinating disease characterized by myelin sheath damage in the central nervous system that affects more than 2.5 million people worldwide and is more common in young adults aged 20-40 years, especially in women. Like physical impairments, cognitive impairments are a common clinical finding in individuals with MS, both in the early and late stages of the disease. Individuals with MS with cognitive impairment have more difficulty than those without cognitive impairment in participating in social and occupational activities, finding a job, working and performing routine household activities. It is also known that there is a high percentage of individuals with MS with upper extremity involvement in the early stages of the disease. Functional problems in the upper extremities lead to restriction of activity and participation in individuals with MS. Although it is stated that there is a high rate of upper extremity problems in individuals with MS, it is seen that they are not sufficiently understood and analyzed. When the literature is examined; evidence-based studies examining the effect of cognitive exercise on motor functions in MS in addition to physical exercises are quite limited. In this context, the subject of this study is to examine the effect of cognitive rehabilitation on upper extremity functions, balance and cognitive functions in individuals with MS.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 19, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

July 19, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

July 16, 2024

Last Update Submit

July 16, 2024

Conditions

Keywords

Multiple SclerosisCognitive RehabilitationLOTCA

Outcome Measures

Primary Outcomes (2)

  • Cognitive status

    Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) was developed to assess basic cognitive abilities. It is a standardized method used between 6-70 years of age. This scale consists of 6 main sections and 26 subtests including orientation, visual perception, spatial perception, motor praxis, visual motor organization and thinking ability. It takes approximately 30-45 minutes to administer.

    Change from baseline at 8 weeks treatment program after.

  • Upper extremity

    Manual Ability Measure-36: The scale includes 23 items with a wide range of difficulty that measure the functional level of patients. Nine Hole Peg Test: Evaluates unilateral fine motor skills in the upper extremity. It requires the participants to first insert the nine sticks one by one into the nine holes and then remove them as quickly as possible against the clock. Box and Block Test: It is used to measure hand gross skill performance.The patient is asked to transfer the maximum number of blocks, one at a time, from one compartment of a wooden box divided into two compartments to the other within 60 seconds. Jebsen - Taylor Hand Function Test: It is an standardized test used to measure fine and gross motor functions of the hand by simulating daily life activities. It consists of 7 subtests: writing, simulated number spinning, lifting small objects, simulated feeding, stacking, moving large light and heavy objects.

    Change from baseline at 8 weeks treatment program after.

Secondary Outcomes (4)

  • Coordination

    Change from baseline at 8 weeks treatment program after.

  • Balance

    Change from baseline at 8 weeks treatment program after.

  • Fatigue

    Change from baseline at 8 weeks treatment program after.

  • Position Sense

    Change from baseline at 8 weeks treatment program after.

Other Outcomes (2)

  • Disability Status

    Change from baseline at 8 weeks treatment program after.

  • Cognitive Status

    Change from baseline at 8 weeks treatment program after.

Study Arms (2)

Treatment group

EXPERIMENTAL

Patients in this group are the group in which a physiotherapy program consisting of cognitive rehabilitation and core-based upper extremity exercises will be applied.

Other: Cognitive RehabilitationOther: Core-based Upper Extremity Exercises

Control group

ACTIVE COMPARATOR

Patients in this group are the group in which a physiotherapy program consisting of core-based upper extremity exercises will be applied.

Other: Core-based Upper Extremity Exercises

Interventions

Cognitive rehabilitation is a treatment method used to regain or improve cognitive abilities.For the cognitive rehabilitation program, the Daily Exercise Package of the Norosoft Program, which mainly includes exercises to improve attention, information processing speed, verbal and visual memory functions, will be applied. Core-based Upper Extremity Exercises Breathing exercises, Core based stabilization and mobilization exercises Upper extremity exercises Coordination ve proprioception exercises

Also known as: Core-based Upper Extremity Exercises
Treatment group

Breathing exercises, Core based stabilization and mobilization exercises Upper extremity exercises Coordination ve proprioception exercises

Control groupTreatment group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18 and 65
  • A definitive diagnosis of MS by a neurologist
  • Having an Expanded Disability Status Scale (EDSS) score below 5.5
  • No cognitive problems (Mini Mental Test score of 24 and above),
  • Graduated from at least primary school
  • No change in medical treatment in the last 6 months,
  • Not having had an attack in the last 3 months and not using pulse steroid therapy
  • Volunteering.

You may not qualify if:

  • Having hearing and vision problems that prevent communication
  • Having a neurological or psychiatric disease other than MS that causes cognitive impairment
  • Pregnancy
  • Oncological diseases
  • Having other vestibular and orthopedic diseases that may affect balance
  • Continue with a different exercise therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Yıldırım Beyazıt University

Ankara, 06010, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Emine İpek Halatcı, MSc

    Ankara Yildirim Beyazıt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emine İpek Halatcı, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
single (outcomes assessor) single (outcomes assessor) the evaulation of the patients will be carried out by a blinded investigator.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assingment dual parallel group design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2024

First Posted

July 19, 2024

Study Start

May 13, 2024

Primary Completion

May 15, 2025

Study Completion

June 15, 2025

Last Updated

July 19, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Indivudual participant data will be available to the responsible researcher.

Locations